SCHEMBL7709217

SCHEMBL7709217

COc1ccccc1-c1cc(N)n2nc(-c3ccccn3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.50
ADORA2A P29274 2/20 0.50
NPC1 O15118 3/20 0.48
TP53 P04637 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 2/20 0.48
GAA P10253 2/20 0.48
PKM P14618 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ATM Q13315 4/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
MTOR P42345 1/20 0.44
PRKDC P78527 1/20 0.44
DCTPP1 Q9H773 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
KLK3 P07288 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703002 0.89 ADORA2A (0.47) GRM5ADORA2ANPC1RAB9ASMN1; SMN2
SCHEMBL7709212 0.86 ADORA2A (0.49) ADORA2ANPC1TP53KDM4EGAA
SCHEMBL7711376 0.85 ADORA2A (0.53) GRM5ADORA2ANPC1TP53RAB9A
SCHEMBL7428533 0.83 ADORA2A (0.60) ADORA2ANPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7431382 0.83 NPC1 (0.52) GRM5ADORA2ANPC1RAB9ASMN1; SMN2
SCHEMBL7708534 0.83 ADORA2A (0.53) GRM5ADORA2ANPC1RAB9AKDM4E
SCHEMBL7708776 0.83 ADORA2A (0.53) GRM5ADORA2ANPC1TP53RAB9A
SCHEMBL7483006 0.81 NPC1 (0.53) GRM5ADORA2ANPC1TP53RAB9A
SCHEMBL7485182 0.81 ADORA2A (0.49) GRM5ADORA2ANPC1RAB9ASMN1; SMN2
SCHEMBL7708845 0.79 ADORA2A (0.54) GRM5ADORA2ANPC1TP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed